Close Menu

ArtusLabs

PE's most recent catch, the latest in a string of recent informatics purchases, markets the Nexxis electronic laboratory notebook; Nexxis iLAB, a laboratory automation platform; and LimsLink, a lab integration software platform.

"We see informatics as a real opportunity," PerkinElmer CEO Robert Friel said during a conference call to discuss the company's Q1 results. Now the company is mulling how to integrate the three new software firms it acquired over the past two months.

PerkinElmer has completed its acquisition of ArtusLabs and has agreed to purchase CambridgeSoft. The combined purchase price for the two software firms totals $220 million.

The two deals for $220 million in aggregate will expand PerkinElmer's informatics and software offerings and enable customers to access and share enterprise-wide data "for faster, more informed scientific decisions."

News Scan: Feb 27, 2009

Premium

DiscoveryBioMed, ArtusLabs, Heptares Therapeutics, Gentronix, GlaxoSmithKline, BioFocus DPI, Eli Lilly, Millipore, Epitome, ChanTest, Applied Cell Sciences, BioTime, Embryome Sciences, Reproductive Genetics Institute of Chicago, Arizona State University Biodesign Institute, VisionGate

The partnership will use ArtusLabs' web-based platform Ensemble for Life Science as the data-management platform.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.